Update on Ongoing Randomised Controlled Trials Evaluating the Protective Effect of Metformin on Abdominal Aortic Aneurysm Progression
- 30 August 2024
- journal article
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (1) , 6-8
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery AneurysmsEuropean Journal of Vascular and Endovascular Surgery, 2024
- Exploring Drug Re-Purposing for Treatment of Abdominal Aortic Aneurysms: a Systematic Review and Meta-analysisEuropean Journal of Vascular and Endovascular Surgery, 2023
- Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysmTrials, 2021
- The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) TrialEuropean Journal of Vascular and Endovascular Surgery, 2021
- Metformin treatment status and abdominal aortic aneurysm disease progressionJournal of Vascular Surgery, 2016
- Prevalence and Associations of Abdominal Aortic Aneurysm Detected through ScreeningAnnals of Internal Medicine, 1997